Effect of start age of breast cancer screening mammography on the risk of false-positive results

Preventive Medicine

Volumn 53, Issue 1-2, 2011, Pages 76-81

  Salas, Dolores ^a   Ibáñez, Josefa ^a   Román, Rubén ^b   Cuevas, Dolores ^c   Sala, Maria ^b   Ascunce, Nieves ^d   Zubizarreta, Raquel ^e   Castells, Xavier ^b  

^a Centre for Public Health Research CSISP   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c Valencian Health Agency   (Spain)

^d INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^e Public Health and Planning Directorate and Health Office and Galicia   (Spain)

Author keywords

Age factors; Breast cancer screening; False positive; Invasive procedures

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; DIGITAL MAMMOGRAPHY; FALSE POSITIVE RESULT; FAMILY HISTORY; FEMALE; HEALTH PROGRAM; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; ONSET AGE; PREDICTIVE VALUE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SCREEN FILM MAMMOGRAPHY;

AGE FACTORS; AGED; BREAST NEOPLASMS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SPAIN;

EID: 79960601891     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2011.04.013     Document Type: Article

References (40)

1. American College of Radiology American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) 2003, American College of Radiology, Reston, Virginia. fourth ed.
2. Armstrong K., Moye E., Williams S., et al. Screening mammography in women 40 to 49years of age: a systematic review for the American College of Physicians. Ann. Intern. Med. 2007, 146:516-526.
3. Ascunce N., Salas D., Zubizarreta R., et al. Cancer screening in Spain. Ann. Oncol. 2010, 21:43-51.
4. Barbaglia G., Macià F., Comas M., et al. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10years of follow-up. Menopause 2009, 16:1061-1064.
5. Benet R.M., Carvajal Garcia-Pando A., Garcia D.P., et al. Hormonal replacement therapy in Spain. Med Clin. 2002, 119(1):4-8. (Barc).
6. Berg W.A. Benefits of screening mammography. JAMA 2010, 303:168-169.
7. Bick U., Diekmann F. Digital mammography: what do we and what don't we know?. Eur. Radiol. 2007, 17:1931-1942.
8. Brett J., Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3years after recall and factors affecting re-attendance. J. Public Health Med. 2001, 23:292-300.
9. Carney P.A., Miglioretti D.L., Yankaskas B.C., et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann. Intern. Med. 2003, 138:168-175.
10. Castells X., Molins E., Macia F. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme. J. Epidemiol. Community Health 2006, 60:316-321.
11. Christiansen C.L., Wang F., Barton M.B., et al. Predicting the cumulative risk of false-positive mammograms. J. Natl. Cancer Inst. 2000, 92:1657-1666.
12. Council of the European Union Council recommendation of 2 December 2003 on cancer screening (2003/878/EC). Off. J. Eur. Union 2003, 327:34-38.
13. Deck W., Kakuma R. Screening Mammography: a Reassessment Montréal (Canada): Agence d'Évaluation des Technologies et des Modes d'Intervention en Santé (AETMIS) 2006.
14. Del Turco M.R., Mantellini P., Ciatto S., et al. Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts. AJR. Am. J. Roentgenol. 2007, 189:860-866.
15. Elmore J., Barton M., Moceri V., et al. Ten-year risk of false positive screening mammograms and clinical breast examination. N. Engl. J. Med. 1998, 338:1089-1096.
16. Elmore J.G., Armstrong K., Lehman C.D., et al. Screening for breast cancer. JAMA 2005, 293:1245-1256.
17. Gotzsche P.C., Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst. Rev. 2009, 4:CD001877.
18. Hofvind S., Thoresen S., Tretli S. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer 2004, 101:1501-1507.
19. Karsa L., Anttila A., Ronco G., et al. Cancer screening in the European Union 2008, Report of the Implementation of the Council. Recommendation on Cancer Screening - First Report, Services of the European Commission, Luxembourg.
20. Kavanagh A.M., Davidson N., Jolley D., et al. Determinants of false positive recall in an Australian mammographic screening program. Breast 2006, 15:510-518.
21. Kerlikowske K., Grady D., Barclay J., et al. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1993, 270:2444-2450.
22. Laya M.B., Larson E.B., Taplin S.H., et al. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J. Natl. Cancer Inst. 1996, 88:643-649.
23. Litherland J.C., Evans A.J., Wilson A.R.M. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme. Clin. Radiol. 1997, 52:276-279.
24. Murphy A.M. Mammography screening for breast cancer: a view from 2 worlds. JAMA 2010, 303:166-167.
25. National Cancer Institute. NCI Statement on Breast Cancer Screening [Internet]. Bethesda: National Cancer Institute aat the National Institutes of Health (US); 2009 Nov 16 [updated 2010 Mar 3, cited 2010 Apr 27]. Available from: http://www.cancer.gov/newscenter/pressreleases/BreastScreen2009.
26. Njor S.H., Olsen A.H., Schwartz W., et al. Predicting the risk of a false-positive test for women following a mammography screening programme. J. Med. Screen. 2007, 14:94-97.
27. Nystrom L., Andersson I., Bjurstam N., et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002, 359:909-919.
28. European guidelines for quality assurance in breast cancer screening and diagnosis 2006, Office for Official Publications of the European Communities, Luxembourg. N. Perry, M. Broeders, C. de Wolf (Eds.).
29. Sala M., Comas M., Macià F., et al. Implementation of digital mammography in a population-based breast cancer screening program: effect of screening round on recall rate and cancer detection. Radiology 2009, 252:31-39.
30. Seradour B., Esteve J., Heid P., et al. Hormone replacement therapy and screening mammography: analysis of the results of the du Rhône programme. J. Med. Screen. 1999, 6:99-102.
31. Singer J., Willett J.B. Describing discrete-time event occurrence data. Applied Longitudinal Data Analysis: Modelling Change and Event Occurrence 2003, 325-356. Oxford University Press, New York.
32. Singer J., Willett J.B. Fitting basic discrete-time hazard models. Applied Longitudinal Data Analysis: Modelling Change and Event Occurrence 2003, 357-467. Oxford University Press, New York.
33. Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009, 50:3-9.
34. Tabar L., Gad A., Holmberg L., et al. Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg. Sweden. Diagn. Imag. Clin. Med. 1985, 54:158-164.
35. Thurfjell E.L., Holmberg L.H., Persson I.R. Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology 1997, 203:339-341.
36. US Preventive Services Task Force Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2009, 151:716-726.
37. US Preventive Services Task Force. Screening for Breast Cancer, 2009 [Internet]. Rockville: Agency for Healthcare Research and Quality; 2009 Dec [updated Dec 2009; cited 2010 Apr 27]. Available from http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm.
38. Woloshin S., Schwartz L.M. The benefits and harms of mammography screening: understanding the trade-offs. JAMA 2010, 303:164-165.
39. Woolf S.H. The 2009 breast cancer screening recommendations of the US Preventive Services Task Force. JAMA 2010, 303:162-163.
40. Yankaskas B.C., Haneuse S., Kapp J.M., et al. Performance of first mammography examination in women younger than 40years. J. Natl. Cancer Inst. 2010, 102:692-701.